Cleared Traditional

K110296 - AXIS-SHIELD ANTI-CCP (FDA 510(k) Clearance)

Aug 2011
Decision
198d
Days
Class 2
Risk

K110296 is an FDA 510(k) clearance for the AXIS-SHIELD ANTI-CCP. This device is classified as a Antibodies, Anti-cyclic Citrullinated Peptide (ccp) (Class II - Special Controls, product code NHX).

Submitted by Axis-Shield Diagnostics, Ltd. (Dundee, Scotland, GB). The FDA issued a Cleared decision on August 18, 2011, 198 days after receiving the submission on February 1, 2011.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5775. The Device Is Used For The Detection Of Anti-cyclic Citrullinated Peptide (ccp) Antibodies In Human Serum Or Plasma As An Aid In The Diagnosis Of Rheumatoid Arthritis..

Submission Details

510(k) Number K110296 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 01, 2011
Decision Date August 18, 2011
Days to Decision 198 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code NHX — Antibodies, Anti-cyclic Citrullinated Peptide (ccp)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5775
Definition The Device Is Used For The Detection Of Anti-cyclic Citrullinated Peptide (ccp) Antibodies In Human Serum Or Plasma As An Aid In The Diagnosis Of Rheumatoid Arthritis.